Received Apr 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 5 | B0005 | IM / LA |
No adverse event reported. Reporting per Moderna after a temperature excursion, vaccine remained viable after the excursion per Moderna.
obesity
vasomotor flush, intertrigo, excess skin of abdominal wall, degenerative disc disease, plantar fasciitis, spinal stenosis, spondylolisthesis-lumbar region, bilateral knee pain, chronic low back pain, bilateral shoulder joint pain, pain in right hip, pain in right knee, meralgia parethetica-left, lumbar radiculopathy, epidural lipomatosis, anal/rectal pain, pre-diabetes, GERD, asthma, obstructive sleep apnea, persistent mood disorder, bipolar disorder, high blood cholesterol, hyperlipidemia, insomnia, morbid obesity, hypocalcemia, abnormal mammogram-right, neutrophilia, history of gastric bypass, obesity
metformin, estradiol, medroxyprogesterone, hydrocortisone cream, gabapentin, fluticasone, ferrous sulfate, cholecalciferol, acetaminophen, albuterol sulfate,
apples, carrots, cats, fruit extracts, macadamia nuts, pear, raw vegetables, pollen
N/A